Literature DB >> 9085458

Disturbed gastric motor activity in patients with human immunodeficiency virus infection.

J W Konturek1, H Fischer, I R van der Voort, W Domschke.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) infection is accompanied by a wide spectrum of disorders that affect the central and peripheral nervous system. Damage to the peripheral and central nervous system, including its autonomic division, may become manifest at any stage of the disease.
METHODS: Twenty HIV-positive patients with abdominal complaints like dyspepsia, dysphagia, vomiting, and nausea underwent several function tests to determine oesophageal motility, gastric motor and electric activity, and gastric emptying rate. The CDC (Center for Disease Control) classification was used to determine the stage of the disease, which varied from B2 to C3. Before gastric motility examinations all patients underwent endoscopy of the upper gastrointestinal (GI) tract, and none of them showed any morphologic changes of the stomach or oesophagus. Biopsy specimens taken during upper GI endoscopy did not show any histologic alterations of the gastric or oesophageal mucosa.
RESULTS: Manometry of the antrum showed an unchanged postprandial (after 200 ml liquid, caloric meal) motility index (MI) when compared with the fasting period (mean fed MI, 174 +/- 43; mean fasting MI, 136 +/- 51). The same was seen for frequency, amplitude, and duration of antral contractions. The electrogastrographic recordings showed basal rhythm of 3 cpm, and no significant changes of the electric pattern were observed postprandially. The amplitude of electric oscillations (power content) significantly increased postprandially when compared with the fasting period. The gastric emptying rate of liquids, measured by means of the 13C-acetate breath test, was faster in HIV patients than in healthy controls. On the other hand, in HIV patients the scintigraphically determined emptying rate of solids was significantly delayed compared with the normal values. There were no significant differences in the oesophageal motility pattern with regard to the amplitude, duration, and propagation of peristaltic waves when compared with the values obtained from healthy volunteers.
CONCLUSION: Our results suggest that HIV-associated visceral neuropathy may present already in relatively early stages of infection and may contribute to abdominal symptoms that occur frequently in these patients.

Entities:  

Mesh:

Year:  1997        PMID: 9085458     DOI: 10.3109/00365529709000198

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

Review 1.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

2.  Effects of HIV-1 Tat on enteric neuropathogenesis.

Authors:  Joy Ngwainmbi; Dipanjana D De; Tricia H Smith; Nazira El-Hage; Sylvia Fitting; Minho Kang; William L Dewey; Kurt F Hauser; Hamid I Akbarali
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

Review 3.  HIV, opiates, and enteric neuron dysfunction.

Authors:  J J Galligan
Journal:  Neurogastroenterol Motil       Date:  2015-04       Impact factor: 3.598

4.  [Achalasia in a patient with HIV/HCV coinfection: detection of HCV in the esophageal tissue].

Authors:  H R Gockel; I Gockel; D G Drescher; H Müller; A Schad; J M Kittner; H Rossmann; H Lang
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

5.  Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.

Authors:  Jessica Robinson-Papp; Alexandra Nmashie; Elizabeth Pedowitz; Emma K T Benn; Mary Catherine George; Sandeep Sharma; Jacinta Murray; Josef Machac; Sherif Heiba; Saurabh Mehandru; Seunghee Kim-Schulze; Allison Navis; Isabel Elicer; Susan Morgello
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

6.  Delayed gastric emptying in human immunodeficiency virus infection: correlation with symptoms, autonomic function, and intestinal motility.

Authors:  P J Neild; K S Nijran; E Yazaki; D F Evans; D L Wingate; R Jewkes; B G Gazzard
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

7.  The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.

Authors:  Jessica Robinson-Papp; Alexandra Nmashie; Elizabeth Pedowitz; Mary Catherine George; Sandeep Sharma; Jacinta Murray; Emma K T Benn; Steven A Lawrence; Josef Machac; Sherif Heiba; Seunghee Kim-Schulze; Allison Navis; Bani Chander Roland; Susan Morgello
Journal:  J Neurovirol       Date:  2019-05-16       Impact factor: 2.643

8.  Nausea and vomiting in HIV/AIDS.

Authors:  Joyce K Anastasi; Bernadette Capili
Journal:  Gastroenterol Nurs       Date:  2011 Jan-Feb       Impact factor: 0.978

9.  Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.

Authors:  Mona Arab-Alameddine; Aurélie Fayet-Mello; Rubin Lubomirov; Michael Neely; Julia di Iulio; Andrew Owen; Marta Boffito; Matthias Cavassini; Huldrych F Günthard; Katharina Rentsch; Thierry Buclin; Manel Aouri; Amalio Telenti; Laurent Arthur Decosterd; Margalida Rotger; Chantal Csajka
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

10.  Upper Gastrointestinal Symptoms Predictive of Candida Esophagitis and Erosive Esophagitis in HIV and Non-HIV Patients: An Endoscopy-Based Cross-Sectional Study of 6011 Patients.

Authors:  Yuta Takahashi; Naoyoshi Nagata; Takuro Shimbo; Takeshi Nishijima; Koji Watanabe; Tomonori Aoki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Akio Mimori; Shinichi Oka; Naomi Uemura; Junichi Akiyama
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.